all the information, none of the junk | biotech • healthcare • life sciences

ATS Gets $3M in Cancer Funding

The National Cancer Institute awarded $3 million to San Diego’s Advanced Targeting Systems, a company that develops and provides products for neuroscience researchers, and has developed technology for targeting specific types of cells. In 1997, for example, ATS developed SP-SAP, a reagent that eliminates specific pain transmission neurons that propagate chronic pain signals. In a statement released today, ATS says it plans to use the institute funding to advance SP-SAP for the next two years to initiate clinical trials for treating cancer pain.

Trending on Xconomy

The Author

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788

By posting a comment, you agree to our terms and conditions.